We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

313 hedge funds and large institutions have $2.96B invested in Editas Medicine in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 110 increasing their positions, 85 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $199M | Put options by funds: $112M

33% more capital invested

Capital invested by funds: $2.23B → $2.96B (+$726M)

29% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 85

2% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 43

0% more funds holding

Funds holding: 312 → 313 (+1)

2.09% less ownership

Funds ownership: 78.99% → 76.9% (-2.1%)

Holders
313
Holders Change
+1
Holders Change %
+0.32%
% of All Funds
5.45%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
44
Increased
110
Reduced
85
Closed
43
Calls
$199M
Puts
$112M
Net Calls
+$87.1M
Net Calls Change
+$61.1M

Top Buyers

Rank Fund Capital Flow
1
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$24.1M
2
NAMA
Nikko Asset Management Americas
New York
+$22.6M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$13.3M
4
DVF
Discovery Value Fund
Singapore
+$13M
5
State Street
State Street
Massachusetts
+$7.77M

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$58.1M
2
Two Sigma Investments
Two Sigma Investments
New York
-$20.9M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.7M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$15.1M
5
Renaissance Technologies
Renaissance Technologies
New York
-$11.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFN
251
Cordasco Financial Network
Florida
$23K – – –
HNB
252
Huntington National Bank
Ohio
$23K – – –
GWS
253
Glassman Wealth Services
Virginia
$21K -$4.76K -129 -25%
LWANC
254
Laurel Wealth Advisors (North Carolina)
North Carolina
$19K +$12.6K +341 New
RG
255
Retirement Group
California
$18K – – –
WIM
256
Westside Investment Management
California
$17.2K -$7.39K -200 -5%
CTC
257
Central Trust Company
Missouri
$17K – – –
WT
258
Whittier Trust
California
$17K – – –
ICM
259
Islay Capital Management
Texas
$17K +$11.1K +300 New
Northwestern Mutual Wealth Management
260
Northwestern Mutual Wealth Management
Wisconsin
$16K +$10.5K +283 New
HIA
261
Harbor Investment Advisory
Maryland
$15K – – –
GI
262
Gradient Investments
Minnesota
$14K – – –
LFG
263
Larson Financial Group
Missouri
$14K – – –
SCA
264
Stonebridge Capital Advisors
Minnesota
$12K +$4.43K +120 +100%
First Manhattan
265
First Manhattan
New York
$11K – – –
RAM
266
Riggs Asset Management
Pennsylvania
$11K – – –
TFA
267
Toth Financial Advisory
Virginia
$11K – – –
TWA
268
TCI Wealth Advisors
Arizona
$11K +$2K +54 +36%
CG
269
Cutler Group
California
$11K +$3.32K +90 +82%
AWA
270
Arkadios Wealth Advisors
Georgia
$11K +$7.39K +200 New
SIS
271
Sound Income Strategies
Florida
$9K +$5.76K +156 New
BDWM
272
Brewin Dolphin Wealth Management
Ireland
$8.5K – – –
COCM
273
Charter Oak Capital Management
New Hampshire
$8K – – –
Daiwa Securities Group
274
Daiwa Securities Group
Japan
$8K – – –
CWP
275
Concord Wealth Partners
Virginia
$8K +$3.58K +97 +206%
9 10
11
12 13

EDIT Hedge Fund Activity: Q2 2021 in Review

313 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2021, worth a combined $2.96B — up 33% from $2.23B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EDIT positions and 43 closed out — a net gain of 1 holder — while 110 added to existing stakes and 85 trimmed.

The largest buyer was Sumitomo Mitsui Trust Group, adding an estimated $24.1M. The largest seller was ARK Investment Management, cutting an estimated $58.1M.

  • 313 institutional investors held Editas Medicine (EDIT) as of Q2 2021, up from 312 in Q1 2021.
  • Funds reported $2.96B of Editas Medicine stock for Q2 2021, up 33% quarter-over-quarter.
  • 44 funds opened new Editas Medicine positions in Q2 2021 and 43 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q2 2021 was Sumitomo Mitsui Trust Group, an estimated $24.1M added.
  • The largest Editas Medicine seller in Q2 2021 was ARK Investment Management, an estimated $58.1M sold.

Based on aggregated 13F filings for Q2 2021.